Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

SAGE open medical case reports

ISSN 2050-313X

3 papers in the library · publishing 2020-2026

Papers

Persistent auditory hallucinations despite hearing aid use in bilateral sensorineural hearing loss without evidence of psychosis.

SAGE open medical case reports January 1, 2026 Bushra Elhusein, Nicole Willis, Sharfi Ahmed et al.

Auditory hallucinations are often associated with psychotic disorders but can also arise from non-psychiatric causes such as hearing loss. This case report describes a woman in her 50s with bilateral sensorineural hearing loss who experienced persistent auditory hallucinations for more than three years. She maintained insight and normal daily functioning, with no other features of psychosis. Neuroimaging was unremarkable, and antipsychotic trials provided minimal benefit. Even after hearing aids improved auditory input, her hallucinations persisted, indicating that symptoms related to sensory deprivation may not resolve immediately with hearing correction. The case illustrates how sensory deprivation-related hallucinations can be misdiagnosed as psychiatric illness, leading to unnecessary interventions.

Acute psychotic and vitamin B12 deficiency in patient with nitrous oxide misuse: A case report.

SAGE open medical case reports January 1, 2024 Hasnaoui Mohammed, Echater Sara, Oneib Bouchra

Chronic nitrous oxide misuse can cause psychiatric complications such as depression, hypomania, and paranoid psychosis with hallucinations. A 25-year-old woman with bizarre behavior, delusions, and hallucinations had low vitamin B12 levels (135 pmol/L) and a normal neurological exam. Treatment with antipsychotics and vitamin B12 resolved her psychosis. The case highlights that acute psychosis can occur in young people, with use ranging from one month to years, and clinicians need greater awareness of nitrous oxide misuse.

Doxazosin for the treatment of nightmare disorder: A diary-based case study.

SAGE open medical case reports January 1, 2020 Ståle Pallesen, Hilde Sofie Hamre, Nina Lang et al.

A patient who developed severe nightmares after an erroneous adrenaline injection tracked their sleep for 280 days while taking 0, 4, or 8 mg of the α1-adrenergic antagonist doxazosin. The 8 mg dose resulted in 55.2% nightmare-free nights, far exceeding the 4.3% nightmare-free nights without the drug (odds ratio = 28.2). Dizziness was reported but not bothersome. The findings suggest doxazosin may help treat posttraumatic stress disorder-related nightmares.